Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q4 2024 data
Ridgeback Capital Investments L.P.'s Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Ridgeback Capital Investments L.P.

โ€ขCIK: 1423994โ€ขFiling: Q4 2024

**Ridgeback Capital Investments L.P.** is a focused investment vehicle currently managing $1M in assets. The fund maintains a concentrated portfolio, with its entirety of holdings allocated to PYXS, representing a $0.6M position. This single-stock concentration suggests a high-conviction, directional strategy within the selected issuer. Investors should note the current single-name exposure profile.

Total AUM
$560.4K
QoQ Performance
N/A
Positions
1
Top 10 Concentration
100.0%
Latest Filing
Q4 2024

Top Holdings Allocation

PYXS
PYXS100.0%

๐Ÿ“ˆ Biggest Buys

PYXS
Pyxis Oncology Inc
NEW
100.0% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q4 2023

BCYC
BICYCLE THERAPEUTICS LTD.
SOLD
$15.3M
โ€”
AFFIMED NV
SOLD
$9.3M

Changes from Q4 2023

NEW1 new position

Historical Filings

Q4 2024Q4 2023